Effects of psychotropic drugs on the thrombin-induced liberation of arachidonate in human platelets

Saudi Medical Journal

Volumn 29, Issue 10, 2008, Pages 1397-1407

  Oruch, Ramadhan ^a   Pryme, Ian F ^a   Holmsen, Holm ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; MEMBRANE LIPID; MYOSIN LIGHT CHAIN; NEUROLEPTIC AGENT; PHOSPHOLIPASE A2 GROUP IV; THROMBIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; EVALUATION; HUMAN; METABOLISM; PHOSPHORYLATION; THROMBOCYTE;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; ARACHIDONIC ACID; BLOOD PLATELETS; CELLS, CULTURED; GROUP IV PHOSPHOLIPASES A2; HUMANS; MEMBRANE LIPIDS; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; THROMBIN;

EID: 58749099429     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bloom F. Neurotransmission and the central nervous system. In: Hardman J, LImbird L, Molinoff P, Ruddon R, editors. Goodman and Gilmann's The Pharmacological Basis of Therapeutics. 9th ed. USA: The Mcgraw-Hill Companies; 1995. p. 287.
2. Baldessarini R. Psychosis and anxiety. In: Hardman J, LImbird L, Molinoff P, Ruddon R, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. The McGraw-USA: Hill Companies; 1995. p. 399.
3. Ricci A, Bronzetti E, Mannino F, Mignini F, Morosetti C, Tayebati SK, et al. Dopamine receptors in human platelets. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 376-382.
4. Calabrese EJ, Baldwin LA. Toxicology rethinks its central belief. Nature 2003; 421: 691-692.
5. Tharmapathy P, Fukami MH, Holmsen H. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. Biochem Pharmacol 2000; 60: 1267-1277.
6. Oruch R, Hodneland E, Pryme IF, Holmsen H. Psychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: A result of receptorindependent drug intercalation in the plasma membrane? Biochim Biophys Acta 2008; 27. [Epub ahead of print]
7. Agasøsler AV, Tungodden LM, Cejka D, Bakstad E, Sydnes LK, Holmsen H. Chlorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature. Biochem Pharmacol 2001; 61: 817-825.
8. Broniec A, Gjerde AU, Ølmheim AB, Holmsen H. Trifluoperazine causes a disturbance in glycerophospholipid monolayers containing phosphatidylserine (PS): effects of pH, acyl unsaturation, and proportion of PS. Langmuir 2007; 23: 694-699.
9. Song C, Holmsen H, Nerdal W. Existence of lipid microdomains in bilayer of dipalmitoyl phosphatidylcholine (DPPC) and 1-stearoyl-2-docosahexenoyl phosphatidylserine (SDPS) and their perturbation by chlorpromazine: a 13C and 31P solid-state NMR study. Biophys Chem 2006; 120: 178-187.
10. Holmsen H, Daniel JL, Dangelmaier CA, Molish I, Rigmaiden M, Smith JB. Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact platelets. Thromb Res 1984; 36: 419-428.
11. Aitdafoun M, Mounier C, Heymans F, Binisti C, Bon C, Godfroid JJ. 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors. Biochem Pharmacol 1996; 51: 737-742.
12. Akiba S, Nagatomo R, Ishimoto T, Sato T. Effect of berbamine on cytosolic phospholipase A2 activation in rabbit platelets. Eur J Pharmacol 1995; 291: 343-350.
13. Lehr M. Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2. J Med Chem 1997; 40: 2694-2705.
14. Nosal R, Jancinova V. Nonreceptor interactions in the pharmacology of blood platelets. Gen Physiol Biophys 1999; 18: 120-125.
15. Nosal R, Jancinova V. Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)). Thromb Res 2002; 105: 339-345.
16. Nerdal W, Gundersen SA, Thorsen V, Hoiland H, Holmsen H. Chlorpromazine interaction with glycerophospholipid liposomes studied by magic angle spinning solid state (13)CNMR and differential scanning calorimetry. Biochim Biophys Acta 2000; 1464: 165-175.
17. Kucia K, Malecki A, Gabryel B, Trzeciak HI. Effect of antidepressants on the phospholipase A2 activity in plasma membranes of the rat brain cortex. Pol J Pharmacol 2003; 55: 5-15.
18. Burke JR, Davern LB, Stanley PL, Gregor KR, Banville J, Remillard R, et al. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. J Pharmacol Exp Ther 2001; 298: 376-385.
19. Hirabayashi T, Murayama T, Shimizu T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull 2004; 27: 1168-1173.
20. Roufogalis BD, Minocherhomjee AM, Al-Jobore A. Pharmacological antagonism of calmodulin. Can J Biochem Cell Biol 1983; 61: 927-933.
21. Withnall MT, Brown TJ, Diocee BK. Calcium regulation of phospholipase A2 is independent of calmodulin. Biochem Biophys Res Commun 1984; 121: 507-513.
22. Hathaway DR, Adelstein RS. Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci U S A 1979; 76: 1653-1657.
23. Daniel JL, Molish IR, Holmsen H. Myosin phosphorylation in intact platelets. J Biol Chem 1981; 256: 7510-7514.
24. Holmsen H, Dangelmaier CA, Holmsen HK. Thrombininduced platelet responses differ in requirement for receptor occupancy. Evidence for tight coupling of occupancy and compartmentalized phosphatidic acid formation. J Biol Chem 1981; 256: 9393-9396.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
26. Borsch-Haubold AG, Ghomashchi F, Pasquet S, Goedert M, Cohen P, Gelb MH, et al. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stressactivated protein kinase pathways. Eur J Biochem 1999; 265: 195-203.
27. Kramer RM, Roberts EF, Um SL, Borsch-Haubold AG, Watson SP, Fisher MJ, et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 1996; 271: 27723-27729.
28. McNicol A, Shibou TS. Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb Res 1998; 92: 19-26.
29. Watanabe T, Hashimoto Y, Teramoto T, Kume S, Naito C, Oka H. Calmodulin-independent inhibition of platelet phospholipase A2 by calmodulin antagonists. Arch Biochem Biophys 1986; 246: 699-709.
30. Nakagawa Y, Waku K. Selective inhibition of free arachidonic acid production in activated alveolar macrophages by calmodulin antagonists. Biochem Biophys Res Commun 1988; 156: 947-953.
31. Rothenberg RJ. Effects of calmodulin inhibitors on rabbit synoviocyte phospholipase A2. Prostaglandins Leukot Med 1987; 29: 61-69.
32. Shaikh NA, Downar E. Effects of chronic amiodarone treatment on cat myocardial phospholipid content and on in vitro phospholipid catabolism. Mol Cell Biochem 1987; 78: 17-25.
33. Means AR, Bagchi IC, VanBerkum MF, Kemp BE. Regulation of smooth muscle myosin light chain kinase by calmodulin. Adv Exp Med Biol 1991; 304: 11-24.
34. Enyeart JJ, Sheu SS, Hinkle PM. Pituitary Ca2+ channels: blockade by conventional and novel Ca2+ antagonists. Am J Physiol 1987; 253 (1 Pt 1): C162-C170.
35. Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS, et al. Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci 2002; 22: 396-403.
36. Hadjimitova V, Bakalova R, Traykov T, Ohba H, Ribarov S. Effect of phenothiazines on protein kinase C-and calciumdependent activation of peritoneal macrophages. Cell Biol Toxicol 2003; 19: 3-12.
37. Xing M, Insel PA. Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells. Adv Clin Care 1996; 97: 1302-1310.
38. Forsell PK, Olsson AO, Andersson E, Nallan L, Gelb MH. Polychlorinated biphenyls induce arachidonic acid release in human platelets in a tamoxifen sensitive manner via activation of group IVA cytosolic phospholipase A2-alpha. Biochem Pharmacol 2005; 71: 144-155.
39. Brindley DN. Intracellular translocation of phosphatidate phosphohydrolase and its possible role in the control of glycerolipid synthesis. Prog Lipid Res 1984; 23: 115-133.
40. Casas J, Gijón MA, Vigo AG, Crespo MS, Balsinde J, Balboa MA. Phosphatidylinositol 4,5-bisphosphate anchors cytosolic group IVA phospholipase A2 to perinuclear membranes and decreases its calcium requirement for translocation in live cells. Mol Biol Cell 2006; 17: 155-162.
41. Mouritsen OG, Andresen TL, Halperin A, Hansen PL, Jakobsen AF, Jensen UB, et al. Activation of interfacial enzymes at membrane surfaces. J Phys Condens Matter 2006; 18: 1293-1304.
42. Takegami S, Kitamura K, Kitade T, Takashima M, Ito M, Nakagawa E, et al. Effects of phosphatidylserine and phosphatidylethanolamine content on partitioning of triflupromazine and chlorpromazine between phosphatidylcholine-aminophospholipid bilayer vesicles and water studied by second-derivative spectrophotometry. Chem Pharm Bull (Tokyo) 2005; 53: 147-150.
43. Parry MJ, Jutila A, Kinnunen PK, Alakoskela JM. A versatile method for determining the molar ligand-membrane partition coefficient. Journal of fluorescence. 2007 Jan;17(1):97-103.
44. Schror K. Antithrombotic drugs in vascular medicine: a historical perspective. Semin Vasc Med 2003; 3: 97-105.
45. Rochette L, Yao-Kouame J, Bralet J, Opie LH. Effects of promethazine on ischemic and reperfusion arrhythmias in rat heart. Fundam Clin Pharmacol 1988; 2: 385-397.
46. Slezak J, Tribulova N, Gabauer I, Ziegelhoffer A, Holec V, Slezak J, Jr. Diminution of injury in reperfused ischemic myocardium by phenothiazines. A quantitative morphological study. Biomed Biochim Acta 1987; 46: S606-S609.
47. Yanagisawa H. Acute myocardial infarction improved by neuroleptic analgesic therapy. South Med J 1990; 83: 839-842.
48. Bakken AM, Staeffler A, Jorgensen HA, Holmsen H. Glycerophospholipid molecular species in platelets and brain tissues -are platelets a good model for neurons? Platelets 2006; 17: 484-492.